Tech Company Financing Transactions
Cortica Funding Round
On 10/4/2023, Cortica raised $40 million in Series D investment from CVS Health Ventures, Ascension Ventures and LRVHealth.
Transaction Overview
Company Name
Announced On
10/4/2023
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds for continued national scaling of whole-child autism value-based care, as well as investments in technology, data capture, clinical decision support, research, and optimization of the clinician and patient experience.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
10201 Wateridge Cir. 450
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Hattangadi
Chief Financial Officer
Briana Elvaiah
Chief Medical Officer
Suzanne Goh
Chief Technical Officer
Benjamin Nathan
President
Erich Mounce
VP - Operations
Cathy Lopez
VP - R & D
Kevin Shapiro
Browse more venture capital transactions:
Prev: 10/4/2023: Orakl Oncology venture capital transaction
Next: 10/4/2023: Lendbuzz venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records on this site come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs